|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Movement Disorder | |||||
| Myoclonus | |||||
| Nervous System Disease | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Movement Disorders | |||||
| Nervous System Diseases | |||||
| 3 | More general conditions related to this trial | ||||
| Central Nervous System Diseases | |||||
| Dyskinesias | |||||
| Neurologic Manifestations | |||||
| Signs and Symptoms | |||||
| 4 | Interventions listed in this trial | ||||
| Magstim Super Rapid Stimulator | |||||
| 5 | Sponsors listed in this trial | ||||
| National Institute of Neurological Disorders and Stroke (NINDS) | |||||